Maritime Toxic-Tort Claims Require Reliable, Injury-Specific Expert Causation Evidence

Dufour v. BP Expl & Prod
United States Court of Appeals for the Fifth Circuit
No. 23-60361 · October 27, 2026

Introduction

The Fifth Circuit affirmed the dismissal of Richard Allen DuFour, Jr.’s claim that exposure to oil-spill cleanup chemicals permanently worsened his preexisting asthma. Writing for the majority, Judge Priscilla Richman concluded that the district court properly excluded DuFour’s causation experts and entered summary judgment for BP Exploration & Production, Incorporated, and BP America Production Company. Judge Andrew S. Oldham dissented.

The opinion’s principal contribution is its express recognition that established toxic-tort causation principles apply under general maritime law to injuries that are not readily observable or have multiple possible causes. Such claims require reliable expert evidence connecting the relevant exposure to the particular injury alleged. The decision also confirms that courts may resolve expert-admissibility challenges without live hearings and may grant summary judgment when exclusion leaves a plaintiff without necessary causation evidence.

The disagreement between the majority and dissent reaches beyond the scientific evidence. It concerns how precisely courts must identify the governing substantive law before deciding whether an expert’s evidence adequately “fits” the plaintiff’s claim.

Background and Procedural History

Following the 2010 Deepwater Horizon disaster, DuFour worked for BP Enterprises for almost three years performing shoreline cleanup and boom decontamination in Pascagoula, Mississippi. He alleged exposure to crude oil and chemical dispersants through inhalation and contact, causing chronic worsening of asthma that he had experienced since childhood.

DuFour sued under the Back-End Litigation Option, or BELO, of the Deepwater Horizon Medical Settlement Agreement. That procedure required him to establish, among other matters, that response-related exposure legally caused his injuries. The case was transferred from the Eastern District of Louisiana to the Southern District of Mississippi following the parties’ venue stipulation.

To establish causation, DuFour offered Dr. Michael Freeman and treating pulmonologist Dr. Shawn French. BP challenged their opinions and sought summary judgment. The district court denied DuFour’s request for an evidentiary hearing, excluded both experts’ causation testimony, and entered judgment for BP.

Summary of the Opinion

  1. Maritime causation principles governed the analysis. The majority concluded that the judicial decisions applying toxic-tort principles supplied, or had created, an applicable maritime rule.
  2. Expert testimony was necessary. Whether chemical exposure chronically aggravated DuFour’s asthma was beyond ordinary juror knowledge and involved potentially competing causes.
  3. No live admissibility hearing was required. The written record provided an adequate basis for evaluating the experts.
  4. Dr. Freeman’s reasoning contained an unsupported inferential gap. The studies did not reliably establish that the relevant exposure caused lasting aggravation of preexisting asthma.
  5. Dr. French’s opinions lacked demonstrated qualifications and reliable methodology for this exposure-specific inquiry. The majority did not resolve the separate dispute over his expert-report obligations.
  6. Summary judgment followed. Without admissible expert causation evidence, DuFour could not establish an essential part of his claim.

Analysis: Precedents Cited and Their Influence

1. Expert Causation Evidence Under Maritime Law

Seaman v. Seacor Marine L.L.C., 326 F. App’x 721 (5th Cir. 2009), supplied the central doctrinal foundation. A vessel captain alleged that chemical exposures caused bladder cancer. That decision required scientific knowledge of harmful exposure levels, evidence that the plaintiff encountered such quantities, and expert testimony explaining medical causation. Although unpublished, it was expressly endorsed in this opinion as consistent with maritime decisions within and outside the circuit.

Seaman v. Seacor Marine L.L.C. drew its exposure formulation from Allen v. Pa. Eng’g Corp., 102 F.3d 194 (5th Cir. 1996), a nonmaritime toxic-tort case involving a hospital maintenance worker. Its significance here is that the majority treated those scientific causation requirements as suitable for maritime toxic-exposure litigation, rather than as rules confined to their original setting.

Wills v. Amerada Hess Corporation, 379 F.3d 32 (2d Cir. 2004), reinforced that conclusion. There, a seaman’s widow alleged that workplace chemical exposure caused cancer. The Second Circuit held that injuries with multiple potential causes required expert testimony even under the Jones Act’s reduced causation burden. The widow’s appeal to the jury’s broad role, supported by Oxley v. City of New York, 923 F.2d 22 (2d Cir. 1991), did not eliminate the need for admissible medical evidence.

The Fifth Circuit’s published decision in Gowdy v. Marine Spill Response Corp., 925 F.3d 200 (5th Cir. 2019), supplied the practical dividing line: ordinary experience may explain a broken leg following a vehicle collision, but not a disease developing after chemical exposure. The majority placed chronic aggravation of asthma on the expert-dependent side of that distinction.

2. General and Specific Causation in BELO Litigation

Knight v. Kirby Inland Marine Inc., 482 F.3d 347 (5th Cir. 2007), requires courts first to identify admissible general-causation evidence and then admissible specific-causation evidence. General causation asks whether an agent can cause the relevant injury; specific causation asks whether it caused that injury in the claimant.

The majority acknowledged that this framework drew from Texas law, particularly Merrell Dow Pharms., Inc. v. Havner, 953 S.W.2d 706 (Tex. 1997). Nevertheless, Knight v. Kirby Inland Marine Inc. itself applied the framework to a Jones Act claim. The opinion contrasted that evidentiary requirement with Brister v. A.W.I., Inc., 946 F.2d 350 (5th Cir. 1991), which describes the Jones Act’s liberal causation standard. A reduced substantive burden does not dispense with reliable scientific evidence.

The court situated its ruling within an existing BELO line:

  • Williams v. BP Expl. & Prod., Inc., 143 F.4th 593 (5th Cir. 2025), provided published authority applying general- and specific-causation requirements to an oil-spill illness claim.
  • Ruffin v. BP Expl. & Prod., Inc., 176 F.4th 855 (5th Cir. 2026), had acknowledged the Texas origins of the framework while explaining that maritime toxic-tort claims had nevertheless been subject to both causation requirements.
  • Prest v. BP Expl. & Prod., Inc., Wunstell v. BP, P.L.C., and Braggs v. BP Expl. & Prod., Inc. supplied unpublished applications. The discussion emphasized that an expert must address not merely whether a chemical is harmful, but the exposure levels at which relevant effects occur.
  • Barrington v. BP Expl. & Prod., Inc., Byrd v. BP Expl. & Prod., Inc., and McGill v. BP Expl. & Prod., Inc. were additional examples of the circuit’s application of these principles.

Outside the circuit, Willis v. Royal Caribbean Cruises, Ltd., 77 F.4th 1332 (11th Cir. 2023), expressly recognized a maritime requirement of medical expert testimony for non-readily observable injuries. In re Deepwater Horizon BELO Cases, 119 F.4th 937 (11th Cir. 2024), applied related general- and specific-causation principles to BELO claims. Together, these decisions supported the majority’s conclusion that its approach reflected maritime doctrine rather than an unexplained importation of state law.

3. Authority to Recognize or Develop Maritime Rules

Great Lakes Insurance SE v. Raiders Retreat Realty Co., 601 U.S. 65 (2024), furnished the majority’s answer to uncertainty about the rule’s precise source. Federal courts follow established maritime rules, and a body of judicial decisions may establish such a rule. Where no established rule exists, federal courts may develop uniform maritime rules.

The opinion explained this authority through the decisions discussed in Great Lakes Insurance SE v. Raiders Retreat Realty Co.:

  • Norfolk S. Ry. Co. v. Kirby, 543 U.S. 14 (2004), supported federal judicial development of maritime decisional law.
  • Air & Liquid Sys. Corp. v. DeVries, 586 U.S. 446 (2019), described the federal court’s common-law role in maritime cases.
  • Wilburn Boat Co. v. Fireman’s Fund Ins. Co., 348 U.S. 310 (1955), supported adherence to established maritime rules.
  • Bisso v. Inland Waterways Corp., 349 U.S. 85 (1955), supported identifying an established rule from judicial decisions.

The majority therefore offered alternative grounds: the relevant toxic-tort requirements were either already established maritime law or had been created through maritime adjudication in the Fifth, Second, and Eleventh Circuits.

4. Expert Reliability, Hearings, and Appellate Review

Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579 (1993), supplied the Rule 702 framework requiring reliable and relevant expert testimony. Burleson v. Tex. Dep’t of Crim. Just., 393 F.3d 577 (5th Cir. 2004), quoting Pipitone v. Biomatrix, Inc., 288 F.3d 239 (5th Cir. 2002), supplied the circuit’s formulation of that framework.

Kumho Tire Co., Ltd. v. Carmichael, 526 U.S. 137 (1999), established that trial judges have broad latitude both in evaluating reliability and in choosing how to conduct that evaluation. Carlson v. Bioremedi Therapeutic Sys., Inc., 822 F.3d 194 (5th Cir. 2016), confirmed that a formal hearing is not invariably necessary, although the court must actually perform its gatekeeping inquiry.

The deferential appellate standard came from Smith v. Chrysler Grp., L.L.C., 909 F.3d 744 (5th Cir. 2018), quoting In re Complaint of C.F. Bean L.L.C., 841 F.3d 365 (5th Cir. 2016). Gen. Elec. Co. v. Joiner, 522 U.S. 136 (1997), Salem v. U.S. Lines Co., 370 U.S. 31 (1962), and Congress & Spring Co. v. Edgar, 99 U.S. 645 (1878), reinforced the longstanding principle that expert-evidence rulings should not be reversed unless manifestly erroneous.

Watts v. Radiator Specialty Co., 990 So.2d 143 (Miss. 2008), provided additional, alternative support. Mississippi’s Supreme Court had upheld exclusion of benzene-causation opinions where the supporting studies lacked exposure information needed for meaningful comparison with the plaintiff. The majority cited this decision to show that Mississippi toxic-tort law also employs demanding reliability principles, not to replace its maritime holding.

5. Expert Exclusion and Summary Judgment

Celotex Corp. v. Catrett, 477 U.S. 317 (1986), framed the relationship between an absent essential evidentiary showing and summary judgment. The majority also emphasized that Daubert v. Merrell Dow Pharms., Inc. expressly permits judgment when scientific evidence cannot support a reasonable finding for the proponent.

The supporting authorities illustrated different procedural applications. Turpin v. Merrell Dow Pharmaceuticals, Inc., 959 F.2d 1349 (6th Cir. 1992), affirmed summary judgment based on insufficient expert causation evidence. Brock v. Merrell Dow Pharmaceuticals, Inc., 874 F.2d 307 (5th Cir. 1989), reversed a plaintiff’s judgment after trial and rendered judgment for the defendant. Kumho Tire Co., Ltd. v. Carmichael upheld expert exclusion at the summary-judgment stage. Collectively, these decisions refuted any suggestion that scientific admissibility must await trial.

6. Treating Physicians and Unresolved Disclosure Requirements

United States v. Williams, No. 20-10433, 2021 WL 2819016 (5th Cir. July 6, 2021), discussed whether treating physicians must provide written reports for opinions developed after treatment for litigation. It cited LaShip, LLC v. Hayward Baker, Inc., 296 F.R.D. 475 (E.D. La. 2013), as an example of a district court imposing that requirement.

Importantly, the majority acknowledged that this question remained unsettled in the circuit. It affirmed Dr. French’s exclusion on independent grounds and expressly declined to resolve the report issue.

Analysis: The Court’s Legal Reasoning

1. Why Maritime Law Applied

Both parties maintained that maritime law governed. DuFour’s allegations also connected the response activities to vessels used for recovering oil, deploying booms, burning oil, and applying dispersants. The settlement agreement required maritime interpretation of the agreement and release.

The majority did not rely solely on that contractual provision. Its decisive reasoning identified a maritime causation rule through precedent and federal common-law authority. This matters because the contractual language concerned interpretation of the settlement instruments, rather than expressly selecting substantive law for every BELO injury claim.

2. Why Dr. Freeman’s Evidence Did Not Fit the Injury Alleged

The majority upheld the district court’s conclusion that Dr. Freeman had not reliably connected his studies to chronic worsening of preexisting asthma. The three studies in his original report did not consistently address the same exposure pathways or the same exposure–disease relationship. None appeared to directly examine the particular worsening alleged.

The Lawrence Study received the closest attention. It involved nearly 25,000 cleanup workers and reported associations between chemical exposure and incident asthma. Its limitations mattered in several related ways:

  • Different population: It excluded people reporting asthma diagnosed before the spill, including someone with DuFour’s history.
  • Different outcome: It assessed the risk of developing asthma, not the severity or lasting aggravation of existing asthma.
  • Outcome definition: Its definition included self-reported wheezing; results were largely attenuated when wheezing was excluded.
  • Incomplete individual comparison: Although some exposure categories had relative risks exceeding 2.0, Dr. Freeman did not establish that DuFour belonged to those categories even apart from his preexisting condition.

The majority distinguished an exposure-related increase in the risk of developing asthma from an exposure-related increase in the severity of existing asthma. A scientifically reasoned explanation might bridge that distinction, but the district court permissibly found the explanation missing here.

This is not a categorical holding that an expert may rely only on studies for which the plaintiff would have qualified. Nor does it announce that relative risk must always exceed 2.0. Those features formed part of a case-specific assessment of whether the expert had justified his extrapolation.

3. Statistical Significance Did Not Resolve Scientific Fit

The dissent emphasized the Lawrence Study’s very small p-value and exposure-related trend. The majority responded that statistical significance does not establish the magnitude, clinical importance, or relevance of an association to the injury being litigated.

That distinction is important. A small p-value can support confidence that an observed association is inconsistent with a specified no-association model. It does not independently establish that the association concerns chronic aggravation, that the claimant experienced a comparable exposure, or that exposure caused the claimant’s condition.

The majority cited the Federal Judicial Center’s Reference Manual on Scientific Evidence for this statistical distinction. The dissent criticized that manual; the majority answered that the relevant proposition also appeared in the earlier edition and was not the subject of the identified criticism. The dispositive issue remained the study’s fit, not the manual’s status.

4. Why Dr. French’s Clinical Opinion Was Insufficient

The district court questioned both disclosure and admissibility. On disclosure, it concluded that DuFour could not introduce new causation opinions through deposition without an appropriate written report. The appellate majority left that issue open.

Instead, it upheld two independent deficiencies. First, the record did not demonstrate that Dr. French’s qualifications extended to the particular chemicals and exposure-specific causation questions presented. This was a finding about the showing made, not a categorical rejection of pulmonologists as causation experts.

Second, Dr. French did not explain how he distinguished cleanup exposure from other possible reasons for worsening asthma. He acknowledged limited knowledge of the substances involved and had not researched potential causes. The court therefore regarded his opinion as resting on chronology and assertion rather than a demonstrated reliable methodology. Treating a patient and expressing medical certainty did not, by themselves, establish a reliable toxicological explanation.

5. Why Neither a Hearing nor Additional Proceedings Were Necessary

The district court had expert reports, declarations, depositions, and extensive briefing. Its familiarity with the litigation supplemented that record; it did not substitute for an actual inquiry. Scientific complexity and an expert’s willingness to explain the opinion did not create an automatic entitlement to live testimony.

The scheduling order, amended several times, also supplied an orderly point for testing the evidence. DuFour did not argue that additional time would produce different or additional expert evidence. Once the existing opinions were properly excluded, the case could be resolved on the record before the court.

The Dissent: Substantive Law Must Define Evidentiary Fit

Judge Oldham’s central objection was that Rule 702 cannot identify the legally relevant causation question without a sufficiently clear choice of substantive law. He relied on the “fit” discussion in Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579 (1993), and the Ninth Circuit’s remand decision bearing the same title, 43 F.3d 1311 (9th Cir. 1995). The latter expressly looked to California tort law when determining what evidence would assist the factfinder.

In re Paoli R.R. Yard PCB Litig., 35 F.3d 717 (3d Cir. 1994), supported his view that substantive causation requirements can affect admissibility. Briggs v. Wash. Metro. Area Transit Auth., 481 F.3d 839 (D.C. Cir. 2007), similarly illustrated that substantive law may determine when expert testimony is necessary.

He disputed each suggested basis for choosing maritime law:

  • Yamaha Motor Corp., U.S.A. v. Calhoun, 516 U.S. 199 (1996), establishes that admiralty jurisdiction does not automatically displace state law.
  • Wilburn Boat Co. v. Fireman’s Fund Ins. Co. and N.H. Ins. Co. v. Martech USA, Inc., 993 F.2d 1195 (5th Cir. 1993), likewise caution against assuming automatic displacement in maritime-contract cases.
  • Ezell v. Hayes Oilfield Const. Co., 693 F.2d 489 (5th Cir. 1982), supported his position that parties’ stipulations about applicable law do not bind the court.
  • The settlement provision, referenced through In re Oil Spill by the Oil Rig “Deepwater Horizon”, 295 F.R.D. 112 (E.D. La. 2013), selected maritime law for interpreting the agreement and release, not expressly for deciding all underlying injury claims.

His fictional spider-bite example illustrated how identical expert evidence might satisfy one jurisdiction’s substantive causation rules but fail another’s. It was an analogy, not an actual precedent establishing a study-eligibility requirement.

On the evidence, Judge Oldham considered the Lawrence Study’s size, statistical strength, and exposure trend sufficient to support an inference that chemicals associated with causing asthma could also worsen it. He believed Dr. Freeman had addressed the study’s limitations and regarded the majority’s distinction between incidence and severity as excessively exacting. He also emphasized Dr. French’s testimony connecting the cleanup work to worsened lung function.

The disagreement therefore concerned both institutional roles and scientific inference: whether the missing bridge was a reliability defect for the judge or a debatable inference for the jury. The majority resolved that question through maritime precedent and deferential review; the dissent found neither the substantive-law identification nor the evidentiary criticism persuasive.

Potential Impact

  • Clearer maritime doctrine: The express endorsement of previously unpublished reasoning strengthens the basis for requiring expert causation evidence in comparable maritime toxic-exposure cases.
  • Greater attention to the precise injury: Evidence that an exposure causes a disease may not, without explanation, establish that it permanently worsens an existing disease.
  • More demanding scientific bridges: Experts should explain differences in study populations, outcomes, exposure routes, and exposure categories rather than assuming those differences are immaterial.
  • Earlier dispositive decisions: Courts may decide admissibility on a developed written record and enter summary judgment when necessary expert evidence fails.
  • Continued limits and disputes: The opinion neither resolves all maritime choice-of-law questions nor settles the treating-physician report issue. The dissent preserves a substantial challenge to using evidentiary gatekeeping without precisely articulating the substantive causation requirement.

The decision consolidates an existing line of authority more than it invents a wholly new causation regime. Its strongest application is to scientifically complex maritime injuries resembling DuFour’s, not to every injury occurring in a maritime setting.

Complex Concepts Simplified

General causation
Can the substance cause the particular kind of injury alleged, at relevant exposure levels?
Specific causation
Did that exposure cause this claimant’s injury?
Scientific “fit”
Reliable research must answer the question the lawsuit actually presents. Research about new asthma does not automatically establish permanent worsening of existing asthma.
Ipse dixit and analytical gap
An expert’s conclusion cannot rest merely on “because I say so.” The reasoning connecting the data to the conclusion must be explained and reliable.
Relative risk
A comparison of outcome frequency between groups. A relative risk above 2.0 means more than twice the comparison group’s risk; it does not automatically prove an individual claim.
P-value
A statistical measure calculated under a specified null model. It is not the probability that the exposure caused the claimant’s injury.
Abuse of discretion
A deferential review standard. The appellate court asks whether the trial judge’s decision exceeded permissible bounds, not whether it would have made the same decision initially.
Summary judgment
Judgment without trial when the record cannot support a genuine factual dispute on an essential legal requirement.

Conclusion

Dufour v. BP Expl & Prod confirms that complex maritime toxic-tort claims require reliable expert evidence tailored to the injury alleged. Statistical associations and clinical chronology cannot replace an adequately explained causal connection.

Its broader significance lies in expressly grounding those requirements in maritime law while affirming robust trial-court gatekeeping. The dissent identifies the enduring counterweight: admissibility analysis must remain connected to the governing substantive law and must not improperly remove reasonable scientific inferences from the jury.